tiprankstipranks
Advertisement
Advertisement
Jagsonpal Pharma Board Approves Unaudited Q3 and Nine-Month FY25 Results
PremiumCompany AnnouncementsJagsonpal Pharma Board Approves Unaudited Q3 and Nine-Month FY25 Results
3M ago
Jagsonpal Pharmaceuticals Schedules Analyst and Investor Meeting
Premium
Company Announcements
Jagsonpal Pharmaceuticals Schedules Analyst and Investor Meeting
5M ago
Jagsonpal Pharmaceuticals Schedules Investor Conference Call for Q2 FY26 Results
Premium
Company Announcements
Jagsonpal Pharmaceuticals Schedules Investor Conference Call for Q2 FY26 Results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100